Biodefense Market is Expected to be Flourished by Increased Government Funding for Biodefense Programs
Biodefense Market Biodefense refers to countermeasures against biological threats, whether naturally occurring pathogens or those used deliberately as bioweapons. It includes early detection of and rapid response to outbreaks, as well as developing vaccines and therapeutics to prevent or treat disease and injury. Key products in the biodefense market include anthrax vaccines, smallpox vaccines, botulism antitoxins, and viral hemorrhagic fever vaccines and drugs. For instance, smallpox vaccine can immunize individuals against smallpox infection. The global Biodefense Market is estimated to be valued at US$ 13.4 Bn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics Increased Government Funding for Biodefense Programs Government agencies across major countries have increased their funding for biodefense preparedness programs in order to strengthen their defenses aga